Neutrophil extracellular trap formation is regulated by CXCR2 in COPD neutrophils

Keywords

• Aged
• Extracellular Traps/*metabolism
• Humans
• Middle Aged
• Neutrophils/drug effects/metabolism
• Pulmonary Disease, Chronic Obstructive/*drug therapy
• Pyrimidines/*therapeutic use
• Receptors, Interleukin-8B/*antagonists & inhibitors
• Sputum/cytology
• Sulfonamides/*therapeutic use
• interest: B. Waschki reports grants from AstraZeneca. Conflict of interest: A.
• Kirsten reports grants from AstraZeneca, and personal fees from AstraZeneca and
• Boehringer Ingelheim. Conflict of interest: A. Malmgren is an employee of
• AstraZeneca. Conflict of interest: K. Rabe reports grants from AstraZeneca, and
• personal fees from AstraZeneca, BerlinChemie, Boehringer Ingelheim, Chiesi,
• Novartis, SanofiAventis, and Teva. Conflict of interest: M. Uddin is an employee
• of AstraZeneca. Conflict of interest: H. Watz reports grants from AstraZeneca,
• personal fees and non-financial support from AstraZeneca, GlaxoSmithKline and
• Novartis, and personal fees from BerlinChemie, Boehringer Ingelheim and Chiesi.